16
Oct 1 (Reuters) – Shield Therapeutics PLC: * SHIELD THERAPEUTICS – POSITIVE EFFICACY AND TOLERANCE IN PEDIATRIC TRIAL * SHIELD THERAPEUTICS PLC – SIGNIFICANT HB IMPROVEMENTS OBSERVED IN TRIAL GROUPS * SHIELD THERAPEUTICS PLC – NO DISCONTINUATIONS IN FERRIC MALTOL GROUP DUE TO ADVERSE EVENTS * SHIELD THERAPEUTICS PLC – NO SERIOUS ADVERSE EVENTS REPORTED IN TRIAL GROUPS Source text: Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
